Your browser doesn't support javascript.
loading
Aggressive surgical management of recurrent intracranial juvenile xanthogranuloma: case report and review of the literature.
AlQazlan, Salman; Albakr, Abdulrahman; Al Towim, Abdullah; Alsaadan, Yazeed; Hassan, Hamdy; Aljerian, Khaldoon; Elwatidy, Sherif.
Afiliação
  • AlQazlan S; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Albakr A; Division of Neurosurgery, Department of Surgery, College of Medicine, King Saud University, Riyadh, Saudi Arabia. Dr.aalbakr@gmail.com.
  • Al Towim A; Division of Neurosurgery, Department of Neurosciences, University of Calgary, Foothills Medical Centre, Calgary, Alberta, Canada. Dr.aalbakr@gmail.com.
  • Alsaadan Y; Department of Neurosurgery, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.
  • Hassan H; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Aljerian K; Department of Radiology and Medical Imaging, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Elwatidy S; Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Childs Nerv Syst ; 36(1): 213-217, 2020 01.
Article em En | MEDLINE | ID: mdl-31385088
ABSTRACT

INTRODUCTION:

Juvenile xanthogranuloma (JXG) with the central nervous system (CNS) involvement is a rare disease entity that remains poorly understood, especially when the condition develops following treatment for Langerhans cell histiocytosis (LCH). CASE REPORT A 21-year-old man who was diagnosed with LCH at age 2, several years following which he developed signs and symptoms of CNS involvement. Magnetic resonance imaging (MRI) of the brain revealed JXG with bilateral choroid plexus involvement. As radiation therapy for the intraventricular masses proved unsuccessful, he underwent two surgical resections. In the following years, he developed another large JXG in the meninges, which was managed conservatively until he required surgery due to symptom progression. Twelve years after the first surgery, the patient is in stable condition with no evidence of recurrence.

CONCLUSION:

Due to the rarity of JXG in the CNS, optimal treatment strategies and the precise duration of therapy remain to be determined. Future studies should aim to develop an appropriate treatment algorithm for such rare cases.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans / Xantogranuloma Juvenil Limite: Adult / Humans / Male Idioma: En Revista: Childs Nerv Syst Assunto da revista: NEUROLOGIA / PEDIATRIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Arábia Saudita

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Histiocitose de Células de Langerhans / Xantogranuloma Juvenil Limite: Adult / Humans / Male Idioma: En Revista: Childs Nerv Syst Assunto da revista: NEUROLOGIA / PEDIATRIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Arábia Saudita